ImmunoGen, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ImmunoGen, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2022.
  • ImmunoGen, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was $30.7M.
  • ImmunoGen, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$73.5M, a 63.4% increase year-over-year.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 60% decline from 2021.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$139M, a 214% decline from 2020.
  • ImmunoGen, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$44.4M, a 57.4% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$223M -$83.6M -60% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 -$139M -$94.9M -214% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$44.4M +$59.8M +57.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$104M +$64.7M +38.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$169M -$72.8M -75.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$96M +$60.7M +38.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 -$157M -$96M -158% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$60.7M Jul 1, 2014 Jun 30, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.